Canada - français - Health Canada

mantra pharma inc - clindamycine (chlorhydrate de clindamycine) - capsule - 300mg - clindamycine (chlorhydrate de clindamycine) 300mg - lincomycins

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - clindamycinum - capsules - clindamycinum 150 mg ut clindamycini hydrochloridum, amylum pregelificatum, talcum, magnesii stearas, lactosum monohydricum 78.8 mg, kapselhülle: gelatina, e 171, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), pro capsula. - les maladies infectieuses - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - clindamycinum - capsules - clindamycinum 300 mg ut clindamycini hydrochloridum, amylum pregelificatum, talcum, magnesii stearas, lactosum monohydricum 147.67 mg, kapselhülle: gelatina, e 171, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), pro capsula. - les maladies infectieuses - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - clindamycinum - granulés pour solution buvable - clindamycinum 75 mg ut clindamycini-2 palmitatis hydrochloridum, simeticonum, poloxamerum 188, saccharum 1.8 g, aromatica (kirschen), e 214 0.6 mg ad granulatum corresp. solutio reconstituta 5 ml. - les maladies infectieuses - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - clindamycinum - gélules - clindamycinum 150 mg ut clindamycini hydrochloridum, maydis amylum, talcum, magnesii stearas, lactosum monohydricum max. 224.13 mg, kapselhülle: gelatina, e 171, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, pro capsula. - les maladies infectieuses - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - clindamycinum - gélules - clindamycinum 300 mg ut clindamycini hydrochloridum, maydis amylum, talcum, magnesii stearas, lactosum monohydricum max. 283.27 mg, kapselhülle: gelatina, e 171, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, pro capsula. - les maladies infectieuses - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - clindamycinum - capsules - clindamycinum 150 mg ut clindamycini hydrochloridum, lactosum monohydricum 214.08 mg, maydis amylum, talcum, magnesii stearas, kapselhülle: gelatina, e 171, drucktinte: lacca, e 172 (nigrum), propylenglycolum, pro capsula. - les maladies infectieuses - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - clindamycinum - capsules - clindamycinum 300 mg ut clindamycini hydrochloridum, lactosum monohydricum 283.24 mg, maydis amylum, talcum, magnesii stearas, kapselhülle: gelatina, e 171, drucktinte: lacca, e 172 (nigrum), propylenglycolum, pro capsula. - les maladies infectieuses - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - clindamycinum - capsules - clindamycinum 150 mg ut clindamycini hydrochloridum, amylum pregelificatum, talcum, magnesii stearas, lactosum monohydricum 78.8 mg, kapselhülle: gelatina, e 171, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), pro capsula. - les maladies infectieuses - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - clindamycinum - capsules - clindamycinum 300 mg ut clindamycini hydrochloridum, amylum pregelificatum, talcum, magnesii stearas, lactosum monohydricum 147.67 mg, kapselhülle: gelatina, e 171, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), pro capsula. - les maladies infectieuses - synthetika